Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19: Omalizumab, Urticaria, COVID-19

Öner Özdemir

doi:10.5826/dpc.1401a78

Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19

Omalizumab, Urticaria, COVID-19

Authors

Öner Özdemir Division of Allergy and Immunology, Department of Pediatrics, Research and Training Hospital of Sakarya University Medical Faculty, Adapazarı, Sakarya, Türkiye

References

Kaya Ö, Keskinkaya Z, Işık Mermutlu S, Oğuz Kılıç S, Öztürk S. Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19? Dermatol Pract Concept. 2023;13(3):e2023145. DOI: 10.5826/dpc.1303a145. PMID: 37557113. PMCID: PMC10412006.

Özdemir Ö. Omalizumab's efficacy and safety against chronic spontaneous urticaria. World Allergy Organ J. 2023;16(8):100808. DOI: 10.1016/j.waojou.2023.100808. PMID: 37638362. PMCID: PMC10458888.

Bostan E, Zaid F, Karaduman A, et al. The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study. J Cosmet Dermatol. 2021;20(11):3369-3375. DOI: 10.1111/jocd.14484. PMID: 34599630. PMCID: PMC8661558.

Özdemir Ö. Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations? Eur J Clin Pharmacol. 2023;79(9):1279-1280. DOI: 10.1007/s00228-023-03532-1. PMID: 37393210.

Ashraf UM, Abokor AA, Edwards JM, et al. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics. 2021;53(2):51-60. DOI: 10.1152/physiolgenomics.00087.2020. PMID: 33275540. PMCID: PMC7900915.

Downloads

Published

2024-01-31

Issue

2024 Vol 14, No 1 | January

Section

Letter to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Özdemir Öner. Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19: Omalizumab, Urticaria, COVID-19. Dermatol Pract Concept. 2024;14(1):e2024078. doi:10.5826/dpc.1401a78